Alhelo H, Kulesza R J
Department of Anatomy, Lake Erie College of Osteopathic Medicine, Erie, PA, United States.
Folia Morphol (Warsz). 2022;81(4):863-873. doi: 10.5603/FM.a2021.0098. Epub 2021 Sep 30.
Autism spectrum disorder (ASD) is a developmental disorder associated with in utero exposure to the antiepileptic valproic acid (VPA) in humans, and similar exposure serves as a validated animal model. Animals exposed to VPA in utero have a number of structural, function and behavioural deficits associated with ASD. Furthermore, VPA-exposed animals have shorter body lengths, lower body and brain weights. This difference in body weight may result from impaired caloric intake due to impaired oropharyngeal function.
Specifically, it is hypothesized that in utero VPA exposure results in fewer lower motor neurons associated with feeding behaviours, that surviving neurons will exhibit dysmorphology and altered balance of excitatory and inhibitory inputs. Further, it is hypothesized that VPA exposure will result in altered oropharyngeal musculature that will impact skull morphology.
These hypotheses were investigated using quantitative morphometrics and immunofluorescence.
Results support dysmorphology and excitatory/inhibitory imbalance and these alterations may contribute to dysphagia and poor weight gain in VPA-exposed animals.
自闭症谱系障碍(ASD)是一种发育障碍,与人类孕期接触抗癫痫药物丙戊酸(VPA)有关,类似的接触可作为一种经过验证的动物模型。孕期接触VPA的动物存在许多与ASD相关的结构、功能和行为缺陷。此外,孕期接触VPA的动物体长较短,体重和脑重较低。体重差异可能是由于口咽功能受损导致热量摄入受损所致。
具体而言,假设孕期接触VPA会导致与进食行为相关的下运动神经元数量减少,存活的神经元将表现出形态异常以及兴奋性和抑制性输入平衡改变。此外,假设接触VPA会导致口咽肌肉组织改变,从而影响颅骨形态。
使用定量形态计量学和免疫荧光对这些假设进行了研究。
结果支持形态异常和兴奋性/抑制性失衡,这些改变可能导致孕期接触VPA的动物出现吞咽困难和体重增加不佳。